Bigul

Sanofi resets footprint in India to be fit for the future, says MD

Sanofi's pre-filled insulin pens, Soliqua, will be available in the market from today
01-04-2024
Bigul

Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Resignation of Director

We wish to inform you that Mr. Marc-Antoine Lucchini (DIN: 08812302), Non-Executive Director, has vide his letter dated 28th March 2024, resigned from the Board of Directors of the Company, with effect from the close of business hours on 28th March 2024.
28-03-2024
Bigul

Sanofi India Ltd - 500674 - Closure of Trading Window

The Trading Window of the Company shall remain closed from 1st April 2024, till 48 hours after the announcement of the Financial Results of the Company for the quarter ended 31st March 2024, to the stock exchanges.
28-03-2024
Bigul

Sanofi India shares rise 4.19% on Cipla tie-up

Cipla to distribute Sanofi's central nervous system medication in India
27-03-2024
Bigul

Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Please find enclosed a Press Release as regards to an exclusive distribution and promotion agreement between Sanofi India Limited (SIL) and Cipla Limited for distribution and promotion of SIL''s Central Nervous System products in India.
26-03-2024
Bigul

Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Please find enclosed a Press Release as regards to an exclusive distribution and promotion agreement between Sanofi India Limited (SIL) and Cipla Limited for distribution and promotion of SIL''s Central Nervous System products in India.
26-03-2024
Bigul

Sanofi India Ltd - 500674 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we would like to inform you that the Company has approved issue of duplicate share certificates requests in lieu of the original share certificates reported lost/misplaced.
22-03-2024
Bigul

Sanofi India Ltd - 500674 - Intimation Of Book Closure Pursuant To Regulation 42 Of SEBI (LODR) Regulations, 2015

Please note that the Register of Members and Share Transfer Books of the Company will remain closed from Saturday, 4th May 2024 to Tuesday, 14th May 2024 (both days inclusive) for the purpose of payment of final dividend for the year ended 31st December 2023. Accordingly, the record date for the payment shall be Friday, 3rd May 2024.
22-03-2024
Bigul

Sanofi India Ltd - 500674 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has received communication from its Registrar and Share Transfer Agent on loss of share certificate(s).
18-03-2024

Sanofi India inks distribution pact with Emcure, but shares trade flat

The share touched a 52-week high of Rs 9,370.35 and a 52-week low of Rs 5,329.70 on 23 February, 2024 and 03 May, 2023, respectively.
14-03-2024
Next Page
Close

Let's Open Free Demat Account